AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1349301 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg LHRH nasal spray
Number of subjects: 123
Study 3933893 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg three times daily
Number of subjects: 26
Study 3933893 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg twice daily
Number of subjects: 26
Study 3933893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 3933893 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 26
Study 3933893 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 26
Study 30054187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 56
Study 30054187 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 56
Study 30193810 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality group (Xbox Kinect game system for 30 minutes per day)
Number of subjects: 35
Study 30193810 — intervention group
Group type: COMPARATOR
Intervention: Control group (Conventional therapy for upper extremity for 60 minutes, 5 times per week for 4 weeks)
Number of subjects: 35
Study 30193810 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality group
Number of subjects: 35
Study 30193810 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 26920144 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography-computed tomography fusion imaging
Number of subjects: 20
Study 26920144 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasonography
Number of subjects: 20
Study 25254207 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai massage (TM)
Number of subjects: 60
Study 25254207 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai herbal compression (THC)
Number of subjects: 60
Study 25254207 — intervention group
Group type: COMPARATOR
Intervention: Oral ibuprofen
Number of subjects: 60
Study 22364818 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinylestradiol/desogestrel
Number of subjects: 450
Study 22364818 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinylestradiol/cyproterone acetate
Number of subjects: 450
Study 22364818 — intervention group
Group type: COMPARATOR
Intervention: Control (nonhormonal contraception)
Number of subjects: 450
Study 21192797 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural sleep intervention (two individual consultations and a follow-up phone call with a trained clinician)
Number of subjects: 198
Study 21192797 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 198
Study 17350981 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual sensor pacing (TT sensor)
Number of subjects: 64
Study 17350981 — intervention group
Group type: EXPERIMENTAL
Intervention: Single sensor pacing (MV sensor)
Number of subjects: 64
Study 17350981 — intervention group
Group type: COMPARATOR
Intervention: No rate adaptive pacing
Number of subjects: 64
Study 15179411 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice‐containing serum
Number of subjects: 5
Study 15179411 — intervention group
Group type: COMPARATOR
Intervention: Plain orange juice (control)
Number of subjects: 5
Study 15179411 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum and purified DHB (in vitro)
Number of subjects: 5
Study 15179411 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum and purified DHB (in Caco‐2 cells)
Number of subjects: 5
Study 11450359 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute ethanol intoxication
Number of subjects: 66
Study 11450359 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol withdrawal syndrome
Number of subjects: 66
Study 11450359 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 66
Study 9543138 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-6 (1 microg/kg, i.v. bolus) with saline
Number of subjects: 9
Study 9543138 — intervention group
Group type: COMPARATOR
Intervention: GHRP-6 (1 microg/kg, i.v. bolus) with GHRH Ant (400 microg/kg, i.v.)
Number of subjects: 9
Study 8092500 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 20
Study 8092500 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 20
Study 8092500 — intervention group
Group type: COMPARATOR
Intervention: Halothane and Isoflurane
Number of subjects: 20
Study 3387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion
Number of subjects: 0
Study 3387508 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 3387508 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 3387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic suggestion (Experiment 2)
Number of subjects: 0
Study 3387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonhypnotic suggestion (Experiment 2)
Number of subjects: 0
Study 3387508 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Experiment 2)
Number of subjects: 0
Study 29049039 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood samples collected immediately after interrupting the medication from peripheral vein and CVC lines.
Number of subjects: 32
Study 29049039 — intervention group
Group type: COMPARATOR
Intervention: Blood samples collected 5 minutes after interrupting the infusion from peripheral vein and CVC lines.
Number of subjects: 32
Study 29049039 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC line used for infusion.
Number of subjects: 32
Study 29049039 — intervention group
Group type: COMPARATOR
Intervention: Other lines used for blood collection.
Number of subjects: 32
Study 27473326 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative cell salvage (CS)
Number of subjects: 110
Study 27473326 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intra-operative cell salvage)
Number of subjects: 110
Study 25649025 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 141
Study 25649025 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 141
Study 23958147 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced high-dose volume radiation therapy (RHDVRT)
Number of subjects: 219
Study 23958147 — intervention group
Group type: COMPARATOR
Intervention: Standard whole-bladder radiation therapy (sRT)
Number of subjects: 219
Study 20542736 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (500 mg/day orally for 3 consecutive days per month for 3-4 years)
Number of subjects: 341
Study 20542736 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical tablets to methylprednisolone)
Number of subjects: 341
Study 20542736 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 341
Study 20542736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study 17705052 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (urokinase 12 h, urokinase 2 h, rtPA 50 mg, rtPA 100 mg) in group I
Number of subjects: 520
Study 17705052 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulants (heparin, nadroparin) in group II
Number of subjects: 520
Study 16314023 — intervention group
Group type: EXPERIMENTAL
Intervention: P-50 (3M) resin composite
Number of subjects: 38
Study 16314023 — intervention group
Group type: EXPERIMENTAL
Intervention: Herculite XR (Kerr) resin composite
Number of subjects: 38
Study 12749247 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg/day)
Number of subjects: 34
Study 12749247 — intervention group
Group type: COMPARATOR
Intervention: Famotidine (40 mg/day) or Nizatidine (300 mg/day)
Number of subjects: 34
Study 12749247 — intervention group
Group type: COMPARATOR
Intervention: No histamine 2 receptor antagonists
Number of subjects: 34
Study 16335001 — intervention group
Group type: EXPERIMENTAL
Intervention: Canada split influenza virus vaccine (trial group)
Number of subjects: 0
Study 16335001 — intervention group
Group type: COMPARATOR
Intervention: Homoimported influenza vaccination (control group)
Number of subjects: 0
Study 10914149 — intervention group
Group type: EXPERIMENTAL
Intervention: Single individual teaching and corrective demonstration session
Number of subjects: 200
Study 10914149 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 200
Study 8834818 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia (GA)
Number of subjects: 20
Study 8834818 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GA)
Number of subjects: 20
Study 2282421 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent treatment (placebo)
Number of subjects: 54
Study 2282421 — intervention group
Group type: COMPARATOR
Intervention: continuous treatment (control)
Number of subjects: 54
Study 7270130 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy and surgery
Number of subjects: 354
Study 7270130 — intervention group
Group type: COMPARATOR
Intervention: Surgery and postoperative radiation therapy
Number of subjects: 354
Study 7270130 — intervention group
Group type: COMPARATOR
Intervention: Surgery and postoperative radiation therapy plus radical radiation therapy (for oral cavity and oropharynx lesions)
Number of subjects: 354
Study 7270130 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 354
Study 31568927 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback intervention with personalized inhaler training informed by data from an inhaler compliance assessment device.
Number of subjects: 152
Study 31568927 — intervention group
Group type: COMPARATOR
Intervention: Demonstration group received inhaler training by physical demonstration with a placebo inhaler.
Number of subjects: 152
Study 31568927 — intervention group
Group type: COMPARATOR
Intervention: Control group received usual care.
Number of subjects: 152
Study 26752416 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate plus MET
Number of subjects: 66
Study 26752416 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus MET
Number of subjects: 66
Study 26775385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedoanalgesia (Group S): 1 mg/kg ketamine and 1 mg/kg propofol for induction, followed by infusion of 100-150 μg kg(‐1) min(‐1) propofol and 0.25 mg kg(‐1) h(‐1) ketamine for maintenance
Number of subjects: 60
Study 26775385 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (Group G): 8% sevoflurane by inhalation with 50% nitrous oxide in oxygen for induction, maintained with sevoflurane (2%) and 50% nitrous oxide in oxygen
Number of subjects: 60
Study 23428307 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-like RF EMF signals at two different intensities
Number of subjects: 22
Study 23428307 — intervention group
Group type: COMPARATOR
Intervention: Sham session
Number of subjects: 22
Study 21334787 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone care program after hospital discharge
Number of subjects: 604
Study 21334787 — intervention group
Group type: COMPARATOR
Intervention: Control group (no telephone care)
Number of subjects: 604
Study 19526504 — intervention group
Group type: EXPERIMENTAL
Intervention: Planar gradient system
Number of subjects: 0
Study 19526504 — intervention group
Group type: COMPARATOR
Intervention: Cylindrical configurations
Number of subjects: 0
Study 18171494 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate resistance strength training (RT) at 60% of 1-Repetition Maximum, 3 times per week for 12 weeks
Number of subjects: 18
Study 18171494 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining period after RT
Number of subjects: 18
Study 18171494 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 18
Study 15122753 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin (RBV) and interferon (IFN-alpha)
Number of subjects: 34
Study 15122753 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (DPD) and Glutathione ester (GSHE)
Number of subjects: 34
Study 15122753 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylmaleate (DEM)
Number of subjects: 34
Study 11495142 — intervention group
Group type: EXPERIMENTAL
Intervention: Epithelized autogenous masticatory mucosa graft (free gingival graft)
Number of subjects: 45
Study 11495142 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous predominately connective tissue graft (connective tissue graft)
Number of subjects: 45
Study 11495142 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix
Number of subjects: 45
Study 9595363 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature labor (39 women)
Number of subjects: 97
Study 9595363 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature parturition with no signs of infection (25 women)
Number of subjects: 97
Study 9595363 — intervention group
Group type: COMPARATOR
Intervention: Term labor (33 women)
Number of subjects: 97
Study 7919750 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast feeding
Number of subjects: 249
Study 7919750 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 249
Study 7919750 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula supplements
Number of subjects: 249
Study 7919750 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox multiple regression analysis
Number of subjects: 249
Study 3046481 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of rifampin-trimethoprim (RIF-TMP)
Number of subjects: 189
Study 3046481 — intervention group
Group type: COMPARATOR
Intervention: 10 days of sulfamethoxazole-trimethoprim (SMX-TMP)
Number of subjects: 189
Study 3046481 — intervention group
Group type: COMPARATOR
Intervention: 6 weeks of sulfamethoxazole-trimethoprim (SMX-TMP)
Number of subjects: 189
Study 31039580 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT) delivered via smartphone app
Number of subjects: 67
Study 31039580 — intervention group
Group type: COMPARATOR
Intervention: Active control (National Cancer Institute’s QuitGuide)
Number of subjects: 67
Study 28142160 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiopronin 500 mg
Number of subjects: 13
Study 28142160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 28142160 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiopronin
Number of subjects: 13
Study 25527243 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 78
Study 23037619 — intervention group
Group type: COMPARATOR
Intervention: Gradient 0%
Number of subjects: 12
Study 23037619 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient 2%
Number of subjects: 12
Study 23037619 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient 7%
Number of subjects: 12
Study 21210272 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical barriers (patient education and communication)
Number of subjects: 178
Study 21210272 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal barriers (lack of trust and knowledge)
Number of subjects: 178
Study 21210272 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural barriers (lack of insurance, facilities, and providers)
Number of subjects: 178
Study 20695290 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Advocates program
Number of subjects: 0
Study 20695290 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 0
Study 17234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 17234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniosacral therapy
Number of subjects: 0
Study 17234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and craniosacral therapy
Number of subjects: 0
Study 17234566 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study 17234566 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 0
Study 17234566 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments from one practitioner
Number of subjects: 0
Study 17234566 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple practitioners
Number of subjects: 0
Study 15199091 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (MVAC: methotrexate, vinblastine, doxorubicin, and cisplatin)
Number of subjects: 268
Study 15199091 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical factors (negative margins)
Number of subjects: 268
Study 15199091 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical factors (>=10 nodes removed)
Number of subjects: 268
Study 15199091 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical factors (positive margins)
Number of subjects: 268
Study 15199091 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical factors (fewer than 10 nodes removed)
Number of subjects: 268
Study 11978332 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine (10 mg/kg per day for 3 days) plus artesunate (4 mg/kg per day for 3 days)
Number of subjects: 941
Study 11978332 — intervention group
Group type: COMPARATOR
Intervention: Amodiaquine (10 mg/kg per day for 3 days) and placebo
Number of subjects: 941
Study 10176148 — intervention group
Group type: EXPERIMENTAL
Intervention: diacerein 100 mg/day plus standard osteoarthritic therapy for 6 months, followed by a 3-month monitoring period without diacerein
Number of subjects: 207
Study 10176148 — intervention group
Group type: COMPARATOR
Intervention: standard therapy alone for the entire 9-month period
Number of subjects: 207
Study 10176148 — intervention group
Group type: EXPERIMENTAL
Intervention: diacerein plus standard therapy
Number of subjects: 207
Study 10176148 — intervention group
Group type: COMPARATOR
Intervention: standard therapy alone
Number of subjects: 207
Study 10176148 — intervention group
Group type: COMPARATOR
Intervention: standard therapy group
Number of subjects: 207
Study 8535807 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES) and stone removal (group 1)
Number of subjects: 83
Study 8535807 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (group 2)
Number of subjects: 83
Study 1688616 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrazine sulfate (60 mg, three times daily)
Number of subjects: 65
Study 1688616 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrazine sulfate
Number of subjects: 65
Study 1688616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 631117 — intervention group
Group type: EXPERIMENTAL
Intervention: Stairclimbing
Number of subjects: 52
Study 631117 — intervention group
Group type: COMPARATOR
Intervention: Lift
Number of subjects: 52
Study 31484539 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arm 1 (not specified in detail)
Number of subjects: 60
Study 31484539 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arm 2 (not specified in detail)
Number of subjects: 60
Study 31484539 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment arm 3 (initial treatment with etanercept and methotrexate)
Number of subjects: 60
Study 31484539 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment to target aimed at inactive disease (all arms)
Number of subjects: 60
Study 27852444 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1899
Study 27852444 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1899
Study 26120902 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound (2-MHz pulsed wave) for 2 hours
Number of subjects: 824
Study 26120902 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound (control group)
Number of subjects: 824
Study 26120902 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound and systemic tissue plasminogen activator
Number of subjects: 824
Study 26120902 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound and systemic tissue plasminogen activator
Number of subjects: 824
Study 23797999 — intervention group
Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate) 240 mg twice daily (BID)
Number of subjects: 0
Study 23797999 — intervention group
Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate) 240 mg three times daily (TID)
Number of subjects: 0
Study 23797999 — intervention group
Group type: COMPARATOR
Intervention: BG-12 (dimethyl fumarate)
Number of subjects: 0
Study 21745113 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing the video screen during flexible cystoscopy (Group 1)
Number of subjects: 86
Study 21745113 — intervention group
Group type: COMPARATOR
Intervention: Not viewing the video screen during flexible cystoscopy (Group 2)
Number of subjects: 86
Study 19846359 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation with manual traction (Group A)
Number of subjects: 39
Study 19846359 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation with intermittent mechanical traction (Group B)
Number of subjects: 39
Study 19846359 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation alone (Group C)
Number of subjects: 39
Study 19846359 — intervention group
Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 39
Study 16917670 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐V Impulse System applied for 2 hours daily for 5 postoperative days
Number of subjects: 41
Study 16917670 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 41
Study 16917670 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐V Impulse System
Number of subjects: 41
Study 14734954 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 0
Study 14734954 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate disodium
Number of subjects: 0
Study 14734954 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 11422030 — intervention group
Group type: EXPERIMENTAL
Intervention: PTU 100 mg three times daily
Number of subjects: 0
Study 11422030 — intervention group
Group type: EXPERIMENTAL
Intervention: PTU plus thyroxine 25 microg once daily
Number of subjects: 0
Study 11422030 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 11422030 — intervention group
Group type: EXPERIMENTAL
Intervention: PTU alone
Number of subjects: 0
Study 9101342 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (7.5 mg)
Number of subjects: 0
Study 9101342 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (7.5 mg)
Number of subjects: 0